TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CBUS

Cibus Global LLC

Healthcare · Biotechnology

1.60$ -1.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CBUS
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-68.6% +27.3% -53.5% +2,991.5% +226.9% +9.0% -99.4% +1,057.3% +134.6% -14.6%
-73.4% +175.5% +96.2% +758.5% +278.5% -18.7% -93.0% -80.3% +1,636.5% -13.6%
-61.8% -121.6% +805.7% -282.6%
+103.8% +105.0% -14.8% +24.0% -9.3% +2.3% +1.9% +266.7% +19.0% -12.4%
+86.9% +121.0% +25.5% +2.5% -13.5% -6.3% -28.7% +110.8% +33.1% -12.6%
+94.3% +109.2% +5.9% +38.2% -13.6% -17.8% -15.8% +1,321.9% -76.8% -12.4%
-98.1% -80.0% +125,600.0% +18.5% -3.7% -0.3% -94.8% +25,089.3% +81.0% +3.8%
-98.1% -80.0% +125,600.0% +18.5% +4.9% -107.3% +0.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?